GBA genotype-Parkinson’s phenotype correlation in a cohort of 252 Italian patients from the Tuscany region

GBA genotype-Parkinson’s phenotype correlation in a cohort of 252 Italian patients from the Tuscany region

Introduction: heterozygous mutations in the glucocerebrosidase gene (GBA1), encoding the lysosomal enzyme β-glucocerebrosidase (GCase) are the most common genetic risk factor for Parkinson’s disease (PD). To assess the frequency of GBA1 variants related to PD in a cohort of Tuscany patients and to d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rodolfo Tonin, Silvia Ramat, Marina Rinaldi, Silvia Falliano, Federica Feo, Francesca Cardona, Camilla Matassini, Guido Mannaioni, Giulia Grigioni, Luca Caremani, Alessandra Govoni, Maria Luisa Della Bona, Giancarlo la Marca, Renzo Guerrini, Amelia Morrone
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Clinical Parkinsonism & Related Disorders
Subjects:	Parkinson’s disease GBA1 gene GBA1 gene carrier GCase activity, GBA1-Parkinson
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590112525000301
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The most common structural variant expected at the GBA1 locus may be detected by a simple amplification method: Implications for screening Parkinson’s disease variants
by: Roberto Rozenberg, et al.
Published: (2025-01-01)

GBA1 Thr408Met mutation in a patient with Parkinson’s disease
by: Yi ZHAO, et al.
Published: (2025-06-01)

Comparative analysis of methods for measuring glucocerebrosidase enzyme activity in patients with Parkinson’s disease with the GBA1 variant
by: Jin Hwangbo, et al.
Published: (2025-04-01)

Nurr1 deficiency impairs autophagy-lysosomal function through GBA-dependent transcriptional regulation in Parkinson’s disease pathogenesis
by: Cheng Cheng, et al.
Published: (2025-06-01)

Case Study of a Rare Genetic Disorder: Gaucher Disease
by: A. Xani, et al.
Published: (2025-06-01)

Distinctive cognitive phenotypes in Parkinson’s disease patients with GBA mutations and without dementia: a multicentre cross-sectional retrospective study
by: Chiara Longo, et al.
Published: (2025-01-01)

Application of CRISPR/Cas9 technology in the modeling of Gaucher disorder
by: Mehran Reyhani-Ardabili, et al.
Published: (2024-12-01)

Application of IVDr NMR spectroscopy to stratify Parkinson’s disease with absolute quantitation of blood serum metabolites and lipoproteins
by: Georgy Berezhnoy, et al.
Published: (2025-05-01)

Novel approaches targeting α-Synuclein for Parkinson's Disease: Current progress and future directions for the disease-modifying therapies
by: David Baggett, et al.
Published: (2024-12-01)

Prodromal Parkinsonian Features in Carriers of Gaucher Disease Compared to Controls
by: Michal Becker-Cohen, et al.
Published: (2025-06-01)

Gaucher's disease - a review of the most important information about the disease in Paediatrics
by: Jakub Jarmołowicz, et al.
Published: (2025-07-01)

Designing Primers with a Plant Signal Peptide to Enhance the Expression of GBA1 in Transgenic Soybean Plants
by: Zainab Tuama Aldahlee
Published: (2021-12-01)

An untargeted metabolomics analysis in feces and brain of Orthoflaviviruses-infected mice
by: Zhiwei Su, et al.
Published: (2025-07-01)

Understanding Gender Expertise in the Post-Truth Era: Media Representations of Gender-Based Analysis Plus in Canada
by: Stephanie Paterson, et al.
Published: (2021-12-01)

An Inversion Model for Suspended Sediment Concentration Based on Hue Angle Optical Classification: A Case Study of the Coastal Waters in the Guangdong-Hong Kong-Macao Greater Bay Area
by: Junying Yang, et al.
Published: (2025-03-01)

Gaucher disease type 3c: Expanding the clinical spectrum of an ultra‐rare disease
by: John S. Wang, et al.
Published: (2024-09-01)

The steady-state level of plasma membrane ceramide is regulated by neutral sphingomyelinase 2
by: Anne G. Ostermeyer-Fay, et al.
Published: (2025-01-01)

Effects of COVID-19 Emergency Response Levels on Air Quality in the Guangdong-Hong Kong-Macao Greater Bay Area, China
by: Jie Li, et al.
Published: (2020-10-01)

Legal Approaches and Regulatory Methods for Fintech in the Guangdong – Hong Kong – Macao Greater Bay Area
by: Y. Kuchina
Published: (2024-03-01)

Spatiotemporal Variation and Influencing Factors of Ecological Quality in the Guangdong-Hong Kong-Macao Greater Bay Area Based on the Unified Remote Sensing Ecological Index over the Past 30 Years
by: Fangfang Sun, et al.
Published: (2025-05-01)

Partial substitution Effect of Pb and Mg on the Structural and Electrical Properties of High Temperature (Hg1-xPbxBa2Ca3-yMgyCu4O10+δ) Superconductor
by: Shaheen S. Aldin Alimardan, et al.
Published: (2019-04-01)

Chinese students’ selection of cross-border cooperative universities for tertiary education: intrinsic and extrinsic motivations
by: Huaqing He
Published: (2025-06-01)

Physical drivers of bio-optical properties in the Guangdong-Hong Kong-Macao Greater Bay Area during the winter dry season
by: Wenlong Xu, et al.
Published: (2025-01-01)

Reduced expression of neurogenesis genes as biomarkers of Parkinson's disease associated with mutations in the <i>GBA</i> gene: validation of the data analysis of transcriptome study
by: A. I. Bezrukova, et al.
Published: (2022-07-01)

Synergistic-development of economy, resources, and environment in Guangdong-Hong Kong-Macao Greater Bay Area and its obstacles: a new sustainable framework
by: Chengxue Yu, et al.
Published: (2024-12-01)

De novo SCN1A missense variant in a patient with Parkinson’s disease
by: Majed Alluqmani, et al.
Published: (2024-11-01)

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
by: Sang‐Min Oh, et al.
Published: (2015-03-01)

Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson's disease
by: Jolanta Dorszewska, et al.
Published: (2025-06-01)

Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4
by: Yu. S. Mironova, et al.
Published: (2018-06-01)

The rs3857059 variant of the SNCA gene is associated with Parkinson’s disease in Mexican Mestizos
by: S. García, et al.
Published: (2016-06-01)

Comparative study of autonomic dysfunction between Parkinson’s disease with LRRK2, PRKN, and GBA mutations
by: Bárbara Maldotti Dalla Corte, et al.
Published: (2025-08-01)

An integrated bioinformatics and machine learning approach to identifying biomarkers connecting parkinson’s disease with purine metabolism-related genes
by: Yao Wang, et al.
Published: (2025-04-01)

Distinct expression of NEAT1 isoforms in Parkinson’s disease models suggests different roles of the variants during the disease course
by: Fanni Annamária Boros, et al.
Published: (2025-04-01)

Activated TBK1 promotes ACSL1-mediated microglia lipid droplet accumulation and neuroinflammation in Parkinson’s disease
by: Chunlei Han, et al.
Published: (2025-07-01)

The rs3857059 variant of the SNCA gene is associated with Parkinson’s disease in Mexican Mestizos
by: S. García, et al.
Published: (2016-06-01)

In silico analysis of hub genes and regulatory networks implicates the putamen in non-motor Parkinson’s disease disorders
by: Stephen Tunmise Akanbi, et al.
Published: (2025-01-01)

The use of Nicotinamide in Parkinson’s disease; A Possible path to the future. Review Article
by: Sarah F Fahmy, et al.
Published: (2023-06-01)

Intervention strategies for Parkinson’s disease: the role of exercise and mitochondria
by: Ganggang Xu, et al.
Published: (2025-05-01)

GBA mutations p.N370S and p.L444P are associated with Parkinson's disease in patients from Northern Brazil
by: Carlos Eduardo de Melo Amaral, et al.

The GLP-1 receptor agonist liraglutide inhibits necroptosis and neuroinflammation in a mouse model of Parkinson’s disease with diabetes co-morbidity
by: Xiaomin Zhang, et al.
Published: (2025-06-01)